CoChat

Dopamine Dysregulation in Reward and Autism Spectrum Disorder

Blum, Kenneth, Bowirrat, Abdalla, Sunder, Keerthy, Thanos, Panayotis K., Hanna, Colin, Gold, Mark S., Dennen, Catherine A., Elman, Igor, Murphy, Kevin T., Makale, Milan T. · 2024 · Brain Sciences
Cited by 47

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Autism spectrum disorder (ASD) is primarily characterized by core deficits in social skills, communication, and cognition and by repetitive stereotyped behaviors. These manifestations are variable between individuals, and ASD pathogenesis is complex, with over a thousand implicated genes, many epigenetic factors, and multiple environmental influences. The mesolimbic dopamine (DA) mediated brain reward system is held to play a key role, but the rapidly expanding literature reveals intricate, nuanced signaling involving a wide array of mesolimbic loci, neurotransmitters and receptor subtypes, and neuronal variants. How altered DA signaling may constitute a downstream convergence of the manifold causal origins of ASD is not well understood. A clear working framework of ASD pathogenesis may help delineate common stages and potential diagnostic and interventional opportunities. Hence, we summarize the known natural history of ASD in the context of emerging data and perspectives to update ASD reward signaling. Then, against this backdrop, we proffer a provisional framework that organizes ASD pathogenesis into successive levels, including (1) genetic and epigenetic changes, (2) disrupted mesolimbic reward signaling pathways, (3) dysregulated neurotransmitter/DA signaling, and finally, (4) altered neurocognitive and social behavior and possible antagonist/agonist based ASD interventions. This subdivision of ASD into a logical progression of potentially addressable parts may help facilitate the rational formulation of diagnostics and targeted treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci14070733

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 134

  1. 2017, A Dopamine Hypothesis of Autism Spectrum Disorder, Dev. Neurosci., 39, 355, 10.1159/000478725 · DOI · Paper page
  2. Baio, 2018, Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014, Surveill. Summ., 67, 1, 10.15585/mmwr.ss6706a1 · DOI · Paper page
  3. Schalbroeck, 2021, Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: An [18F]-FDOPA PET/CT study, Transl. Psychiatry, 11, 47, 10.1038/s41398-020-01174-w · DOI
  4. Salama, 2014, Orquestic regulation of neurotransmitters on reward-seeking behavior, Int. Arch. Med., 7, 29, 10.1186/1755-7682-7-29 · DOI
  5. Baik, 2020, Stress and the dopaminergic reward system, Exp. Mol. Med., 52, 1879, 10.1038/s12276-020-00532-4 · DOI · Paper page
  6. Mineur, 2019, The role of acetylcholine in negative encoding bias: Too much of a good thing?, Eur. J. Neurosci., 53, 114, 10.1111/ejn.14641 · DOI · Paper page
  7. Coddington, 2023, Mesolimbic dopamine adapts the rate of learning from action, Nature, 614, 294, 10.1038/s41586-022-05614-z · DOI · Paper page
  8. Dunigan, 2022, Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards, Addict. Neurosci., 2, 100011, 10.1016/j.addicn.2022.100011 · DOI
  9. Peters, 2021, Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System, Trends Neurosci., 44, 464, 10.1016/j.tins.2021.02.001 · DOI · Paper page
  10. Paval, 2023, The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence, Int. Rev. Neurobiol., 173, 1, 10.1016/bs.irn.2023.08.009 · DOI
  11. Kohls, 2011, Atypical Brain Responses to Reward Cues in Autism as Revealed by Event-Related Potentials: A Systematic Review and Meta-analysis, J. Autism Dev. Disord., 41, 1523, 10.1007/s10803-011-1177-1 · DOI · Paper page
  12. Matyjek, 2023, Reward responsiveness in autism and autistic traits—Evidence from neuronal, autonomic, and behavioural levels, NeuroImage Clin., 38, 103442, 10.1016/j.nicl.2023.103442 · DOI
  13. Mandic-Maravic, V., Grujicic, R., Milutinovic, L., Munjiza-Jovanovic, A., and Pejovic-Milovancevic, M. (2022). Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment. Front. Psychiatry, 12. · DOI
  14. DiCarlo, G.E., and Wallace, M.T. (2021). Modeling dopamine dysfunction in autism spectrum disorder: From invertebrates to vertebrates. Neurosci. Biobehav. Rev., 133. · DOI · Paper page
  15. Horder, 2018, Glutamate and GABA in autism spectrum disorder—A translational magnetic resonance spectroscopy study in man and rodent models, Transl. Psychiatry, 8, 106, 10.1038/s41398-018-0155-1 · DOI · Paper page
  16. Whalley, 2011, Converging pathways, Nat. Rev. Neurosci., 12, 372, 10.1038/nrn3062 · DOI
  17. Mahony, C., and O’Ryan, C. (2022). A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology. Front. Psychiatry, 13. · DOI
  18. Jiang, 2022, Signalling pathways in autism spectrum disorder: Mechanisms and therapeutic implications, Signal Transduct. Target. Ther., 7, 229, 10.1038/s41392-022-01081-0 · DOI · Paper page
  19. Port, R.G., Gandal, M.J., Roberts, T.P.L., Siegel, S.J., and Carlson, G.C. (2014). Convergence of circuit dysfunction in ASD: A common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology. Front. Cell. Neurosci., 8. · DOI
  20. Supekar, 2018, Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism: A journal of neurology, Brain, 141, 2795
  21. Fernandez, 2017, Syndromic autism spectrum disorders: Moving from a clinically defined to a molecularly defined approach, Dialog- Clin. Neurosci., 19, 353, 10.31887/DCNS.2017.19.4/sscherer · DOI · Paper page
  22. Rodriguez-Gomez, D.A., Garcia-Guaqueta, D.P., Charry-Sánchez, J.D., Sarquis-Buitrago, E., Blanco, M., Velez-Van-Meerbeke, A., and Talero-Gutiérrez, C. (2021). A systematic review of common genetic variation and biological pathways in autism spectrum disorder. BMC Neurosci., 22. · DOI
  23. Salem, 2013, Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients, Sci. World J., 2013, 670621, 10.1155/2013/670621 · DOI
  24. Sun, 2020, Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size, Mol. Psychiatry, 25, 1822, 10.1038/s41380-018-0078-5 · DOI · Paper page
  25. Ho, K.S., Wassman, E.R., Baxter, A.L., Hensel, C.H., Martin, M.M., Prasad, A., Twede, H., Vanzo, R.J., and Butler, M.G. (2016). Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Int. J. Mol. Sci., 17. · DOI
  26. Ousley, O., Evans, A.N., Fernandez-Carriba, S., Smearman, E.L., Rockers, K., Morrier, M.J., Evans, D.W., Coleman, K., and Cubells, J. (2017). Examining the Overlap between Autism Spectrum Disorder and 22q11.2 Deletion Syndrome. Int. J. Mol. Sci., 18. · DOI
  27. Michaelovsky, E., Frisch, A., Carmel, M., Patya, M., Zarchi, O., Green, T., Basel-Vanagaite, L., Weizman, A., and Gothelf, D. (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med. Genet., 13. · DOI · Paper page
  28. Grandy, 1989, Cloning of the cDNA and gene for a human D2 dopamine receptor, Proc. Natl. Acad. Sci. USA, 86, 9762, 10.1073/pnas.86.24.9762 · DOI · Paper page
  29. Grandy, 1989, The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP, Am. J. Hum. Genet., 45, 778
  30. Ariza, M., Garolera, M., Jurado, M.A., Garcia-Garcia, I., Hernan, I., Sánchez-Garre, C., Vernet-Vernet, M., Sender-Palacios, M.J., Marques-Iturria, I., and Pueyo, R. (2012). Dopamine genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and executive function: Their interaction with obesity. PLoS ONE, 7. · DOI
  31. Berlin, 2000, Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor, Int. J. Neuropsychopharmacol., 3, 35, 10.1017/S1461145700001711 · DOI
  32. Suzuki, 2009, Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice, Hum. Mol. Genet., 18, 1652, 10.1093/hmg/ddp086 · DOI
  33. Zhao, F., Zhang, H., Wang, P., Cui, W., Xu, K., Chen, D., Hu, M., Li, Z., Geng, X., and Wei, S. (2022). Oxytocin and serotonin in the modulation of neural function: Neurobiological underpinnings of autism-related behavior. Front. Neurosci., 16. · DOI
  34. Molosh, 2014, Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase, Nat. Neurosci., 17, 1583, 10.1038/nn.3822 · DOI
  35. Williams, 2022, Future Prospects for Epigenetics in Autism Spectrum Disorder, Mol. Diagn. Ther., 26, 569, 10.1007/s40291-022-00608-z · DOI
  36. Eshraghi, A.A., Liu, G., Kay, S.-I.S., Eshraghi, R.S., Mittal, J., Moshiree, B., and Mittal, R. (2018). Epigenetics and Autism Spectrum Disorder: Is There a Correlation?. Front. Cell. Neurosci., 12. · DOI
  37. Breton, C.V., Landon, R., Kahn, L.G., Enlow, M.B., Peterson, A.K., Bastain, T., Braun, J., Comstock, S.S., Duarte, C.S., and Hipwell, A. (2021). Exploring the evidence for epigenetic regulation of environmental influences on child health across generations. Commun. Biol., 4. · DOI · Paper page
  38. Tsujimura, K., Shiohama, T., and Takahashi, E. (2022). microRNA Biology on Brain Development and Neuroimaging Approach. Brain Sci., 12. · DOI
  39. Vella, M.C., and Slack, F.J.C. (2005). elegans microRNAs. WormBook. · DOI
  40. Yoon, 2018, Epigenetics and epitranscriptomics in temporal patterning of cortical neural progenitor competence, J. Cell Biol., 217, 1901, 10.1083/jcb.201802117 · DOI · Paper page
  41. Zhao, H., Mao, X., Zhu, C., Zou, X., Peng, F., Yang, W., Li, B., Li, G., Ge, T., and Cui, R. (2022). GABAergic System Dysfunction in Autism Spectrum Disorders. Front. Cell Dev. Biol., 9. · DOI · Paper page
  42. Loke, Y.J., Hannan, A.J., and Craig, J.M. (2015). The Role of Epigenetic Change in Autism Spectrum Disorders. Front. Neurol., 6. · DOI · Paper page
  43. Yip, 2009, Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: An in situ hybridization study, Autism Res., 2, 50, 10.1002/aur.62 · DOI
  44. Yip, 2008, IncreasedGAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction, J. Neurosci. Res., 86, 525, 10.1002/jnr.21520 · DOI
  45. Ginsberg, M.R., Rubin, R.A., Falcone, T., Ting, A.H., and Natowicz, M.R. (2012). Brain Transcriptional and Epigenetic Associations with Autism. PLoS ONE, 7. · DOI · Paper page
  46. Wang, 2012, MicroRNAs in learning, memory, and neurological diseases, Learn. Mem., 19, 359, 10.1101/lm.026492.112 · DOI · Paper page
  47. Havranek, 2024, Oxytocin, GABA, and dopamine interplay in autism, Endocr. Regul., 58, 105, 10.2478/enr-2024-0012 · DOI
  48. Bukatova, 2021, Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice, Neurochem. Res., 46, 3342, 10.1007/s11064-021-03435-6 · DOI
  49. Yoo, T., Cho, H., Lee, J., Park, H., Yoo, Y.-E., Yang, E., Kim, J.Y., Kim, H., and Kim, E. (2018). GABA Neuronal Deletion of Shank3 Exons 14–16 in Mice Suppresses Striatal Excitatory Synaptic Input and Induces Social and Locomotor Abnormalities. Front. Cell. Neurosci., 12. · DOI · Paper page
  50. Lisco, G., De Tullio, A., Iovino, M., Disoteo, O., Guastamacchia, E., Giagulli, V.A., and Triggiani, V. (2023). Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes. Biomedicines, 11. · DOI
  51. Poppi, L.A., Ho-Nguyen, K.T., Shi, A., Daut, C.T., and Tischfield, M.A. (2021). Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders. Cells, 10. · DOI
  52. Lemos, 2019, Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor, J. Neurosci., 39, 5647, 10.1523/JNEUROSCI.0479-19.2019 · DOI
  53. Schmidt, 2019, Nucleus accumbens activation is linked to salience in social decision making, Eur. Arch. Psychiatry Clin. Neurosci., 269, 701, 10.1007/s00406-018-0947-6 · DOI
  54. Walle, 2024, Nucleus accumbens D1- and D2-expressing neurons control the balance between feeding and activity-mediated energy expenditure, Nat. Commun., 15, 2543, 10.1038/s41467-024-46874-9 · DOI
  55. Bouarab, C., Thompson, B., and Polter, A.M. (2019). VTA GABA Neurons at the Interface of Stress and Reward. Front. Neural Circuits, 13. · DOI · Paper page
  56. Li, 2019, Role of Descending Dopaminergic Pathways in Pain Modulation, Curr. Neuropharmacol., 17, 1176, 10.2174/1570159X17666190430102531 · DOI
  57. Deperrois, N., Moiseeva, V., and Gutkin, B. (2019). Minimal Circuit Model of Reward Prediction Error Computations and Effects of Nicotinic Modulations. Front. Neural Circuits, 12. · DOI
  58. Loonen, 2013, New insights into the mechanism of drug-induced dyskinesia, CNS Spectrums, 18, 15, 10.1017/S1092852912000752 · DOI
  59. Zinger, 2011, The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson′ s Disease, Park. Dis., 2011, 716859
  60. Grillner, 2016, The Basal Ganglia Over 500 Million Years, Curr. Biol., 26, R1088, 10.1016/j.cub.2016.06.041 · DOI · Paper page
  61. Pretegiani, E., and Optican, L.M. (2017). Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes. Front. Neurol., 8. · DOI
  62. Partanen, J., and Achim, K. (2022). Neurons gating behavior—Developmental, molecular and functional features of neurons in the Substantia Nigra pars reticulata. Front. Neurosci., 16. · DOI
  63. Walter, B.L., and Shaikh, A.G. (2014). Encyclopedia of the Neurological Sciences, Academic Press. [2nd ed.].
  64. Galtieri, 2017, Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons, eLife, 6, e30352, 10.7554/eLife.30352 · DOI
  65. Futami, 1995, Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta, Neurosci. Res., 21, 331, 10.1016/0168-0102(94)00869-H · DOI · Paper page
  66. Collins, 2020, Heterogeneity in striatal dopamine circuits: Form and function in dynamic reward seeking, J. Neurosci. Res., 98, 1046, 10.1002/jnr.24587 · DOI · Paper page
  67. Skirzewski, 2022, Continuous cholinergic-dopaminergic updating in the nucleus accumbens underlies approaches to reward-predicting cues, Nat. Commun., 13, 7924, 10.1038/s41467-022-35601-x · DOI
  68. Suzuki, 2021, M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons, Eur. J. Neurosci., 53, 796, 10.1111/ejn.15074 · DOI
  69. Myslivecek, J. (2021). Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum. Biomedicines, 9. · DOI
  70. Coimbra, 2016, Activation of D2 dopamine receptor-expressing neurons in the nucleus accumbens increases motivation, Nat. Commun., 7, 11829, 10.1038/ncomms11829 · DOI · Paper page
  71. Gittis, 2012, Striatal microcircuitry and movement disorders, Trends Neurosci., 35, 557, 10.1016/j.tins.2012.06.008 · DOI · Paper page
  72. Gagnon, 2017, Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice, Sci. Rep., 7, 41432, 10.1038/srep41432 · DOI · Paper page
  73. Lipton, D.M., Gonzales, B.J., and Citri, A. (2019). Dorsal Striatal Circuits for Habits, Compulsions and Addictions. Front. Syst. Neurosci., 13. · DOI · Paper page
  74. Kwon, H.G., and Jang, S.H. (2014). Differences in neural connectivity between the substantia nigra and ventral tegmental area in the human brain. Front. Hum. Neurosci., 8. · DOI
  75. Martig, 2011, Ventral tegmental area and substantia nigra neural correlates of spatial learning, Learn. Mem., 18, 260, 10.1101/lm.1895211 · DOI
  76. Brown, R.E., and McKenna, J.T. (2015). Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal. Front. Neurol., 6. · DOI
  77. Vadakkan, 2021, Framework for internal sensation of pleasure using constraints from disparate findings in nucleus accumbens, World J. Psychiatry, 11, 681, 10.5498/wjp.v11.i10.681 · DOI
  78. Li, 2020, A neuroimaging biomarker for striatal dysfunction in schizophrenia, Nat. Med., 26, 558, 10.1038/s41591-020-0793-8 · DOI · Paper page
  79. Kosillo, P., and Bateup, H.S. (2021). Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models. Front. Neural Circuits, 15. · DOI
  80. Howard, 2017, Dynamic Nigrostriatal Dopamine Biases Action Selection, Neuron, 93, 1436, 10.1016/j.neuron.2017.02.029 · DOI · Paper page
  81. Uchida, 2018, Multiple Dopamine Systems: Weal and Woe of Dopamine, Cold Spring Harb. Symp. Quant. Biol., 83, 83, 10.1101/sqb.2018.83.037648 · DOI
  82. Afjei, 2019, A Neural Circuit Mechanism for Encoding Aversive Stimuli in the Mesolimbic Dopamine System, Neuron, 101, 133, 10.1016/j.neuron.2018.11.005 · DOI · Paper page
  83. Hamid, 2016, Mesolimbic dopamine signals the value of work, Nat. Neurosci., 19, 117, 10.1038/nn.4173 · DOI · Paper page
  84. Mohebi, 2019, Dissociable dopamine dynamics for learning and motivation, Nature, 570, 65, 10.1038/s41586-019-1235-y · DOI · Paper page
  85. Bruining, 2020, Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics, Sci. Rep., 10, 9195, 10.1038/s41598-020-65500-4 · DOI · Paper page
  86. Stavropoulos, 2018, Oscillatory rhythm of reward: Anticipation and processing of rewards in children with and without autism, Mol. Autism, 9, 4, 10.1186/s13229-018-0189-5 · DOI
  87. Romaniuk, 2021, Glutamate and functional connectivity—support for the excitatory-inhibitory imbalance hypothesis in autism spectrum disorders, Psychiatry Res. Neuroimaging, 313, 111302, 10.1016/j.pscychresns.2021.111302 · DOI
  88. Smolders, 1997, Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis, J. Neurochem., 68, 1942, 10.1046/j.1471-4159.1997.68051942.x · DOI
  89. Wise, 2009, Roles for nigrostriatal—Not just mesocorticolimbic—Dopamine in reward and addiction, Trends Neurosci., 32, 517, 10.1016/j.tins.2009.06.004 · DOI · Paper page
  90. Luo, 2016, Dopaminergic Neurons and Brain Reward Pathways, Am. J. Pathol., 186, 478, 10.1016/j.ajpath.2015.09.023 · DOI · Paper page
  91. Rios, A., Nonomura, S., Kato, S., Yoshida, J., Matsushita, N., Nambu, A., Takada, M., Hira, R., Kobayashi, K., and Sakai, Y. (2023). Reward expectation enhances action-related activity of nigral dopaminergic and two striatal output pathways. Commun. Biol., 6. · DOI
  92. Hollon, 2021, Nigrostriatal dopamine signals sequence-specific action-outcome prediction errors, Curr. Biol., 31, 5350, 10.1016/j.cub.2021.09.040 · DOI
  93. Humphrys, 2024, Activation of Multiple G Protein Pathways to Characterize the Five Dopamine Receptor Subtypes Using Bioluminescence Technology, ACS Pharmacol. Transl. Sci., 7, 834, 10.1021/acsptsci.3c00339 · DOI
  94. Mishra, 2018, Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson’s disease, J. Exp. Neurosci., 12, 1179069518779829, 10.1177/1179069518779829 · DOI · Paper page
  95. Gurevich, 2016, G protein-coupled receptor kinases as regulators of dopamine receptor functions, Pharmacol. Res., 111, 1, 10.1016/j.phrs.2016.05.010 · DOI · Paper page
  96. García-Domínguez, I., Suárez-Pereira, I., Santiago, M., Pérez-Villegas, E.M., Bravo, L., López-Martín, C., Roca-Ceballos, M.A., García-Revilla, J., Espinosa-Oliva, A.M., and Rodríguez-Gómez, J.A. (2021). Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour. Prog. Neuro-Psychopharmacology Biol. Psychiatry, 104. · DOI
  97. South, 2017, Anxiety and ASD: Current Progress and Ongoing Challenges, J. Autism Dev. Disord., 47, 3679, 10.1007/s10803-017-3322-y · DOI
  98. Phan, 2021, Engrailed 2 deficiency and chronic stress alter avoidance and motivation behaviors, Behav. Brain Res., 413, 113466, 10.1016/j.bbr.2021.113466 · DOI
  99. Cannon, 2003, Reward without Dopamine, J. Neurosci., 23, 10827, 10.1523/JNEUROSCI.23-34-10827.2003 · DOI · Paper page
  100. Robertson, 2016, Reduced GABAergic Action in the Autistic Brain, Curr. Biol., 26, 80, 10.1016/j.cub.2015.11.019 · DOI · Paper page
  101. Ford, T.C., Nibbs, R., and Crewther, D.P. (2017). Glutamate/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits. PLoS ONE, 12. · DOI
  102. Fatemi, 2014, Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism, J. Autism Dev. Disord., 44, 1833, 10.1007/s10803-014-2078-x · DOI
  103. Shinohe, 2006, Increased serum levels of glutamate in adult patients with autism, Prog. Neuro-Psychopharmacology Biol. Psychiatry, 30, 1472, 10.1016/j.pnpbp.2006.06.013 · DOI · Paper page
  104. Said, 2013, Normal binocular rivalry in autism: Implications for the excitation/inhibition imbalance hypothesis, Vis. Res., 77, 59, 10.1016/j.visres.2012.11.002 · DOI · Paper page
  105. Wang, 2017, Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism, J. Clin. Investig., 127, 1978, 10.1172/JCI87997 · DOI · Paper page
  106. Andersson, 2021, Serotonin transporter availability in adults with autism—A positron emission tomography study, Mol. Psychiatry, 26, 1647, 10.1038/s41380-020-00868-3 · DOI
  107. Cavalcante, 2017, Modulation of the storage of social recognition memory by neurotransmitter systems in the insular cortex, Behav. Brain Res., 334, 129, 10.1016/j.bbr.2017.07.044 · DOI
  108. Barkus, E., and Badcock, J.C. (2019). A Transdiagnostic Perspective on Social Anhedonia. Front. Psychiatry, 10. · DOI · Paper page
  109. Wang, 2020, The role of dopamine in reward-related behavior: Shining new light on an old debate, J. Neurophysiol., 124, 309, 10.1152/jn.00323.2020 · DOI
  110. Masten, 2011, An fMRI investigation of responses to peer rejection in adolescents with autism spectrum disorders, Dev. Cogn. Neurosci., 1, 260, 10.1016/j.dcn.2011.01.004 · DOI
  111. Brandenburg, C., Soghomonian, J.-J., Zhang, K., Sulkaj, I., Randolph, B., Kachadoorian, M., and Blatt, G.J. (2020). Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry. Front. Cell. Neurosci., 14. · DOI
  112. Gerfen, C.R. (2023). Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective. Front. Synaptic Neurosci., 14. · DOI
  113. Soghomonian, J.J. (2024). The cortico-striatal circuitry in autism-spectrum disorders: A balancing act. Front. Cell. Neurosci., 17. · DOI
  114. Girgis, 2016, Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO, Psychopharmacology, 233, 3503, 10.1007/s00213-016-4382-y · DOI
  115. Pedrosa, 2021, Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis, Curr. Neuropharmacol., 19, 538, 10.2174/1570159X18666200529151741 · DOI
  116. Olotu, 2021, Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D3 dopamine receptor over D2 dopamine receptor, J. Mol. Recognit., 34, e2885, 10.1002/jmr.2885 · DOI
  117. Hermans, 2023, Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness, Br. J. Clin. Pharmacol., 89, 3026, 10.1111/bcp.15800 · DOI
  118. Cohen, 2012, Adverse effects of second-generation antipsychotics in children and adolescents: A Bayesian meta-analysis, J. Clin. Psychopharmacol., 32, 309, 10.1097/JCP.0b013e3182549259 · DOI · Paper page
  119. Lee, A., Choo, H., and Jeon, B. (2022). Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. Int. J. Mol. Sci., 23. · DOI
  120. Eissa, N., Venkatachalam, K., Jayaprakash, P., Yuvaraju, P., Falkenstein, M., Stark, H., and Sadek, B. (2022). Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism. Pharmaceuticals, 15. · DOI
  121. Cosi, 2021, Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist, Eur. J. Pharmacol., 890, 173635, 10.1016/j.ejphar.2020.173635 · DOI
  122. Venkatachalam, K., Eissa, N., Al Awad, M., Jayaprakash, P., Zhong, S., Stölting, F., Stark, H., and Sadek, B. (2021). The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions. Biomed. Pharmacother., 138. · DOI
  123. Matta, 2019, The influence of neuroinflammation in Autism Spectrum Disorder, Brain Behav. Immun., 79, 75, 10.1016/j.bbi.2019.04.037 · DOI · Paper page
  124. Tamouza, R., Volt, F., Richard, J.-R., Wu, C.-L., Bouassida, J., Boukouaci, W., Lansiaux, P., Cappelli, B., Scigliuolo, G.M., and Rafii, H. (2022). Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review. Front. Cell Dev. Biol., 10. · DOI
  125. Jembrek, 2015, GABA Receptors: Pharmacological Potential and Pitfalls, Curr. Pharm. Des., 21, 4943, 10.2174/1381612821666150914121624 · DOI · Paper page
  126. Cogram, P., Deacon, R.M.J., Warner-Schmidt, J.L., von Schimmelmann, M.J., Abrahams, B.S., and During, M.J. (2019). Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome. Front. Behav. Neurosci., 13. · DOI
  127. 2021, The The dopamine hypothesis of autism spectrum disorder revisited: Current status and future prospects, Dev. Neurosci., 43, 73, 10.1159/000515751 · DOI
  128. Kramer, 2018, Combinatorial Expression of Grp and Neurod6 Defines Dopamine Neuron Populations with Distinct Projection Patterns and Disease Vulnerability, eneuro, 5, ENEURO.0152-18.2018, 10.1523/ENEURO.0152-18.2018 · DOI · Paper page
  129. Blum, 2018, The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD), Int. J. Genom. Data Min., 2018, 115
  130. Blum, 2023, Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS), Clin. Exp. Psychol., 9, 8
  131. Dennen, C.A., Blum, K., Bowirrat, A., Thanos, P.K., Elman, I., Ceccanti, M., Badgaiyan, R.D., McLaughlin, T., Gupta, A., and Bajaj, A. (2022). Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. J. Pers. Med., 12. · DOI
  132. Jensen, 2022, Modern Biomarkers for Autism Spectrum Disorder: Future Directions, Mol. Diagn. Ther., 26, 483, 10.1007/s40291-022-00600-7 · DOI
  133. Santarone, M.E., Zambrano, S., Zanotta, N., Mani, E., Minghetti, S., Pozzi, M., Villa, L., Molteni, M., and Zucca, C. (2023). EEG Features in Autism Spectrum Disorder: A Retrospective Analysis in a Cohort of Preschool Children. Brain Sci., 13. · DOI
  134. Ayoub, M.J., Keegan, L., Tager-Flusberg, H., and Gill, S.V. (2022). Neuroimaging Techniques as Descriptive and Diagnostic Tools for Infants at Risk for Autism Spectrum Disorder: A Systematic Review. Brain Sci., 12. · DOI

Cited by

See all 47

Metadata

Authors
Blum, K., Bowirrat, A., Sunder, K., Thanos, P. K., Hanna, C., Gold, M. S., Dennen, C. A., Elman, I., Murphy, K. T., & Makale, M. T.
Venue
Brain Sciences
Publisher
MDPI AG
Published
2024-07-22
Volume
14
Issue
7
Pages
733
ISSN
2076-3425
Cited by
47
References
51
Language
en
Funders
PeakLogic Inc.

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine Dysregulation in Reward and Autism Spectrum Disorder. https://app.cochat.ai/papers/10.3390/brainsci14070733
The paper
Blum, K., Bowirrat, A., Sunder, K., Thanos, P. K., Hanna, C., Gold, M. S., Dennen, C. A., Elman, I., Murphy, K. T., & Makale, M. T. (2024). Dopamine Dysregulation in Reward and Autism Spectrum Disorder. Brain Sciences. https://doi.org/10.3390/brainsci14070733

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.